AC Immune SA (ACIU) stock
ACIUNasdaqPharmaceutical PreparationsFiscal year ends December 31
$2.11+0.02 (+0.96%)
Close on Nov 17, 2026Market cap $214.68MP/E –Yield –
AC Immune operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
AC Immune's operating cash flow for the twelve months ending Dec 31, 2022 was -CHF 73.57M. For fiscal 2025 it was -CHF 69.26M, down 205.2% from the year before. The highest annual figure on record is CHF 65.84M in fiscal 2024.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -CHF 69.26M | -205.2% |
| FY2024 | Dec 31, 2024 | CHF 65.84M | – |
| FY2023 | Dec 31, 2023 | -CHF 60.41M | – |
| FY2022 | Dec 31, 2022 | -CHF 73.57M | – |
| FY2021 | Dec 31, 2021 | -CHF 65.69M | – |
| FY2020 | Dec 31, 2020 | -CHF 59.52M | -207.8% |
| FY2019 | Dec 31, 2019 | CHF 55.22M | – |
| FY2018 | Dec 31, 2018 | -CHF 44.08M | – |
| FY2017 | Dec 31, 2017 | -CHF 22.09M | – |
| FY2016 | Dec 31, 2016 | -CHF 5.65M | -112.8% |
| FY2015 | Dec 31, 2015 | CHF 44.08M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2022 | Dec 31, 2022 | -CHF 17.41M | – |
| Q3 FY2022 | Sep 30, 2022 | -CHF 13.54M | – |
| Q4 FY2021 | Dec 31, 2021 | -CHF 17.83M | – |
See a number that looks wrong?